IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Mantle cell lymphoma (MCL) is an aggressive lymphoma sub-type with poor prognosis and high 18F-FDG avidity at PET/CT; nowadays, no validated criteria for PET/CT in treatment response evaluation and prediction of outcome are present. The aim of study was to investigate whether the metabolic PET/CT features may predict treatment evaluation and prognosis in MCL.

Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in mantle cell lymphoma

Albano, Domenico;Bosio, Giovanni;Giubbini, Raffaele;Bertagna, Francesco
2019-01-01

Abstract

Mantle cell lymphoma (MCL) is an aggressive lymphoma sub-type with poor prognosis and high 18F-FDG avidity at PET/CT; nowadays, no validated criteria for PET/CT in treatment response evaluation and prediction of outcome are present. The aim of study was to investigate whether the metabolic PET/CT features may predict treatment evaluation and prognosis in MCL.
2019
LS7_2 Diagnostic tools (e.g. genetic, imaging)
ANNALS OF NUCLEAR MEDICINE
sì
2-s2.0-85064191666
WOS:000474530800001
Esperti anonimi
Inglese
Internazionale
30929200
18F-FDG PET/CT; MTV; Mantle cell lymphoma; Prognosis; TLG
8
info:eu-repo/semantics/article
262
Albano, Domenico; Bosio, Giovanni; Bianchetti, Nicola; Pagani, Chiara; Re, Alessandro; Tucci, Alessandra; Giubbini, Raffaele; Bertagna, Francesco...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
none
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11379/514575
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 29
  • Scopus 50
  • ???jsp.display-item.citation.isi??? 45
social impact